Paradoxical roles of FAK in tumor cell migration and metastasis

Cell Cycle

Volumn 8, Issue 21, 2009, Pages 3474-3479

  Zheng, Yanhua ^a   Lu, Zhimin ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Cell migration; Dephosphorylation; FAK; Metastasis; Phosphorylation; Ras

Indexed keywords

FOCAL ADHESION KINASE; RAS PROTEIN;

CANCER CELL; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; FOCAL ADHESION; HUMAN; METASTASIS; ONCOGENE; PROTEIN DEPHOSPHORYLATION; PROTEIN PHOSPHORYLATION; REVIEW; TUMOR CELL;

EID: 70449709094     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.8.21.9846     Document Type: Review

References (62)

1. Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002; 2:563-572 (Pubitemid 37328923)
2. Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, et al. Cell migration: integrating signals from front to back. Science (New York, NY) 2003; 302:1704-1709 (Pubitemid 37505725)
3. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell 2002; 110:673-687
4. Mitra SK, Hanson DA, Schlaepfer DD. Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol 2005; 6:56-68.
5. McLean GW, Carragher NO, Avizienyte E, Evans J, Brunton VG, Frame MC. The role of focal-adhesion kinase in cancer - a new therapeutic opportunity. Nat Rev Cancer 2005; 5:505-515 (Pubitemid 40942827)
6. Parsons JT. Focal adhesion kinase: the first ten years. J Cell Sci 2003; 116:1409-1416 (Pubitemid 36527488)
7. Ilic D, Furuta Y, Kanazawa S, Takeda N, Sobue K, Nakatsuji N, et al. Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 1995; 377:539-544
8. Hanks SK, Ryzhova L, Shin NY, Brabek J. Focal adhesion kinase signaling activities and their implications in the control of cell survival and motility. Front Biosci 2003; 8:982-996
9. Ma A, Richardson A, Schaefer EM, Parsons JT. Serine phosphorylation of focal adhesion kinase in interphase and mitosis: a possible role in modulating binding to p130(Cas). Mol Biol Cell 2001; 12:1-12. (Pubitemid 32060574)
10. Yamakita Y, Totsukawa G, Yamashiro S, Fry D, Zhang X, Hanks SK, et al. Dissociation of FAK/ p130(CAS)/c-Src complex during mitosis: role of mitosis-specific serine phosphorylation of FAK. J Cell Biol 1999; 144:315-324 (Pubitemid 29066034)
11. Bianchi M, De Lucchini S, Marin O, Turner DL, Hanks SK, Villa-Moruzzi E. Regulation of FAK Ser-722 phosphorylation and kinase activity by GSK3 and PP1 during cell spreading and migration. Biochem J 2005; 391:359-370 (Pubitemid 41532434)
12. 2+/calmodulin-dependent kinase II. J Biol Chem 2005; 280:24212-24220 Epub 2005.
13. Grigera PR, Jeffery ED, Martin KH, Shabanowitz J, Hunt DF, Parsons JT. FAK phosphorylation sites mapped by mass spectrometry. J Cell Sci 2005; 118:4931-4935 (Pubitemid 41672425)
14. Hunger-Glaser I, Fan RS, Perez-Salazar E, Rozengurt E. PDGF and FGF induce focal adhesion kinase (FAK) phosphorylation at Ser-910: dissociation from Tyr-397 phosphorylation and requirement for ERK activation. J Cell Physiol 2004; 200:213-222 (Pubitemid 38880205)
15. Hunger-Glaser I, Salazar EP, Sinnett-Smith J, Rozengurt E. Bombesin, lysophosphatidic acid and epidermal growth factor rapidly stimulate focal adhesion kinase phosphorylation at Ser-910: requirement for ERK activation. J Biol Chem 2003; 278:22631-22643 Epub 2003.
16. Xie Z, Sanada K, Samuels BA, Shih H, Tsai LH. Serine 732 phosphorylation of FAK by Cdk5 is important for microtubule organization, nuclear movement and neuronal migration. Cell 2003; 114:469-482 (Pubitemid 37100995)
17. Imaizumi M, Nishimura M, Takeuchi S, Murase M, Hamaguchi M. Role of tyrosine specific phosphorylation of cellular proteins, especially EGF receptor and p125FAK in human lung cancer cells. Lung Cancer 1997; 17:69-84. (Pubitemid 27261493)
18. Moon HS, Park WI, Choi EA, Chung HW, Kim SC. The expression and tyrosine phosphorylation of E-cadherin/catenin adhesion complex, and focal adhesion kinase in invasive cervical carcinomas. Int J Gynecol Cancer 2003; 13:640-646
19. Grisaru-Granovsky S, Salah Z, Maoz M, Pruss D, Beller U, Bar-Shavit R. Differential expression of protease activated receptor 1 (Par1) and pY397FAK in benign and malignant human ovarian tissue samples. Int J Cancer 2005; 113:372-378 (Pubitemid 40038703)
20. Sood AK, Coffin JE, Schneider GB, Fletcher MS, DeYoung BR, Gruman LM, et al. Biological significance of focal adhesion kinase in ovarian cancer: role in migration and invasion. Am J Pathol 2004; 165:1087-1095
21. Cance WG, Harris JE, Iacocca MV, Roche E, Yang X, Chang J, et al. Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes. Clin Cancer Res 2000; 6:2417-2423
22. McLean GW, Komiyama NH, Serrels B, Asano H, Reynolds L, Conti F, et al. Specific deletion of focal adhesion kinase suppresses tumor formation and blocks malignant progression. Genes & development 2004; 18:2998-3003. (Pubitemid 39658168)
23. Lahlou H, Sanguin-Gendreau V, Zuo D, Cardiff RD, McLean GW, Frame MC, et al. Mammary epithelial-specific disruption of the focal adhesion kinase blocks mammary tumor progression. Proc Natl Acad Sci USA 2007; 104:20302-20307
24. Zhao J, Guan JL. Signal transduction by focal adhesion kinase in cancer. Cancer Metastasis Rev 2009; 28:35-49.
25. Schaller MD. FAK and paxillin: regulators of N-cadherin adhesion and inhibitors of cell migration? J Cell Biol 2004; 166:157-159
26. Antonyak MA, Cerione RA. Ras and the FAK paradox. Mol Cell 2009; 35:141-142
27. Gabriel B, zur Hausen A, Stickeler E, Dietz C, Gitsch G, Fischer DC, et al. Weak expression of focal adhesion kinase (pp125FAK) in patients with cervical cancer is associated with poor disease outcome. Clin Cancer Res 2006; 12:2476-2483
28. Ayaki M, Komatsu K, Mukai M, Murata K, Kameyama M, Ishiguro S, et al. Reduced expression of focal adhesion kinase in liver metastases compared with matched primary human colorectal adenocarcinomas. Clin Cancer Res 2001; 7:3106-3112 (Pubitemid 32963831)
29. Ohta R, Yamashita Y, Taketomi A, Kitagawa D, Kuroda Y, Itoh S, et al. Reduced expression of focal adhesion kinase in intrahepatic cholangiocarcinoma is associated with poor tumor differentiation. Oncology 2006; 71:417-422 Epub 2007. (Pubitemid 47573706)
30. Carroll RE, Matkowskyj KA, Tretiakova MS, Battey JF, Benya RV. Gastrin-releasing peptide is a mitogen and a morphogen in murine colon cancer. Cell Growth Differ 2000; 11:385-393
31. Levy P, Robin H, Kornprobst M, Capeau J, Cherqui G. Enterocytic differentiation of the human Caco-2 cell line correlates with alterations in integrin signaling. J Cell Physiol 1998; 177:618-627 (Pubitemid 28541586)
32. Nakagawa K, Sogo S, Hioki K, Tokunaga R, Taketani S. Acquisition of cell adhesion and induction of focal adhesion kinase of human colon cancer Colo 201 cells by retinoic acid-induced differentiation. Differentiation 1998; 62:249-257 (Pubitemid 28165708)
33. Rognoni JB, Pichard V, Honore S, Rigot V, Lehmann M, Roccabianca M, et al. Convergent effects of growth factors, hormones and fibronectin are necessary for the enterocyte differentiation of a colon adenocarcinoma cell line (HT29-D4). Differentiation 1998; 63:305-317 (Pubitemid 28474950)
34. Cui Y, Liao YC, Lo SH. Epidermal growth factor modulates tyrosine phosphorylation of a novel tensin family member, tensin3. Mol Cancer Res 2004; 2:225-232 (Pubitemid 39031083)
35. Lu Z, Jiang G, Blume-Jensen P, Hunter T. Epidermal growth factor-induced tumor cell invasion and metastasis initiated by dephosphorylation and downregulation of focal adhesion kinase. Mol Cell Biol 2001; 21:4016-4031 (Pubitemid 32476463)
36. Thelemann A, Petti F, Griffin G, Iwata K, Hunt T, Settinari T, et al. Phosphotyrosine signaling networks in epidermal growth factor receptor overexpressing squamous carcinoma cells. Mol Cell Proteomics 2005; 4:356-376 Epub 2005.
37. Yamanaka I, Koizumi M, Baba T, Yamashita S, Suzuki T, Kudo R. Epidermal growth factor increased the expression of alpha2beta1-integrin and modulated integrin-mediated signaling in human cervical adenocarcinoma cells. Exp Cell Res 2003; 286:165-174
38. Caceres M, Guerrero J, Martinez J. Overexpression of RhoA-GTP induces activation of the Epidermal Growth Factor Receptor, dephosphorylation of focal adhesion kinase and increased motility in breast cancer cells. Exp Cell Res 2005; 309:229-238 (Pubitemid 41191237)
39. Guo HB, Randolph M, Pierce M. Inhibition of a specific N-glycosylation activity results in attenuation of breast carcinoma cell invasiveness-related phenotypes: inhibition of epidermal growth factor-induced dephosphorylation of focal adhesion kinase. J Biol Chem 2007; 282:22150-22162 Epub 2007. (Pubitemid 47195758)
40. Bose R, Molina H, Patterson AS, Bitok JK, Periaswamy B, Bader JS, et al. Phosphoproteomic analysis of Her2/neu signaling and inhibition. Proc Natl Acad Sci USA 2006; 103:9773-9778 Epub 2006. (Pubitemid 43993573)
41. Vadlamudi RK, Adam L, Nguyen D, Santos M, Kumar R. Differential regulation of components of the focal adhesion complex by heregulin: role of phosphatase SHP-2. J Cell Physiol 2002; 190:189-199 (Pubitemid 34027821)
42. Guvakova MA, Surmacz E. The activated insulin-like growth factor I receptor induces depolarization in breast epithelial cells characterized by actin filament disassembly and tyrosine dephosphorylation of FAK, Cas and paxillin. Exp Cell Res 1999; 251:244-255 (Pubitemid 29406538)
43. Lynch L, Vodyanik PI, Boettiger D, Guvakova MA. Insulin-like growth factor I controls adhesion strength mediated by alpha5beta1 integrins in motile carcinoma cells. Mol Biol Cell 2005; 16:51-63. Epub 2004. (Pubitemid 40024290)
44. Manes S, Mira E, Gomez-Mouton C, Zhao ZJ, Lacalle RA, Martinez AC. Concerted activity of tyrosine phosphatase SHP-2 and focal adhesion kinase in regulation of cell motility. Mol Cell Biol 1999; 19:3125-3135 (Pubitemid 29144557)
45. Cai T, Lei QY, Zha XL. TGFbeta1 rapidly reduced hepatocarcinoma cells adhesion on to fibronectin and stimulated FAK dephosphorylation. Shi Yan Sheng Wu Xue Bao 2000; 33:333-339
46. Easley CAt, Brown CM, Horwitz AF, Tombes RM. CaMK-II promotes focal adhesion turnover and cell motility by inducing tyrosine dephosphorylation of FAK and paxillin. Cell Motil Cytoskeleton 2008; 65:662-674
47. 2+ signaling. J Biol Chem 2006; 281:31093-31105
48. Wang FM, Liu HQ, Liu SR, Tang SP, Yang L, Feng GS. SHP-2 promoting migration and metastasis of MCF-7 with loss of E-cadherin, dephosphorylation of FAK and secretion of MMP-9 induced by IL-1beta in vivo and in vitro. Breast Cancer Res Treat 2005; 89:5-14. (Pubitemid 40228442)
49. Zhang Z, Lin SY, Neel BG, Haimovich B. Phosphorylated alpha-actinin and protein-tyrosine phosphatase 1B coregulate the disassembly of the focal adhesion kinase x Src complex and promote cell migration. J Biol Chem 2006; 281:1746-1754 (Pubitemid 43752492)
50. Moissoglu K, Gelman IH. v-Src rescues actin-based cytoskeletal architecture and cell motility and induces enhanced anchorage independence during oncogenic transformation of focal adhesion kinase-null fibroblasts. J Biol Chem 2003; 278:47946-47959 Epub 2003.
51. Tsutsumi R, Takahashi A, Azuma T, Higashi H, Hatakeyama M. Focal adhesion kinase is a substrate and downstream effector of SHP-2 complexed with Helicobacter pylori CagA. Mol Cell Biol 2006; 26:261-276
52. Yano H, Mazaki Y, Kurokawa K, Hanks SK, Matsuda M, Sabe H. Roles played by a subset of integrin signaling molecules in cadherin-based cell-cell adhesion. J Cell Biol 2004; 166:283-295 (Pubitemid 38988780)
53. Schubbert S, Shannon K, Bollag G. Hyperactive Ras in developmental disorders and cancer. Nat Rev Cancer 2007; 7:295-308. (Pubitemid 46480970)
54. Zheng Y, Xia Y, Hawke D, Halle M, Tremblay ML, Gao X, et al. FAK phosphorylation by ERK primes ras-induced tyrosine dephosphorylation of FAK mediated by PIN1 and PTP-PEST. Mol Cell 2009; 35:11-25.
55. Vignjevic D, Montagnac G. Reorganisation of the dendritic actin network during cancer cell migration and invasion. Semin Cancer Biol 2008; 18:12-22. Epub 2007. (Pubitemid 350266367)
56. Matkowskyj KA, Keller K, Glover S, Kornberg L, Tran-Son-Tay R, Benya RV. Expression of GRP and its receptor in well-differentiated colon cancer cells correlates with the presence of focal adhesion kinase phosphorylated at tyrosines 397 and 407. J Histochem Cytochem 2003; 51:1041-1048 (Pubitemid 36919981)
57. Furuyama K, Doi R, Mori T, Toyoda E, Ito D, Kami K, et al. Clinical significance of focal adhesion kinase in resectable pancreatic cancer. World J Surg 2006; 30:219-226 (Pubitemid 43162494)
58. Oktay MH, Oktay K, Hamele-Bena D, Buyuk A, Koss LG. Focal adhesion kinase as a marker of malignant phenotype in breast and cervical carcinomas. Hum Pathol 2003; 34:240-245 (Pubitemid 36356676)
59. Madan R, Smolkin MB, Cocker R, Fayyad R, Oktay MH. Focal adhesion proteins as markers of malignant transformation and prognostic indicators in breast carcinoma. Hum Pathol 2006; 37:9-15. (Pubitemid 41790497)
60. Frisch SM, Vuori K, Ruoslahti E, Chan-Hui PY. Control of adhesion-dependent cell survival by focal adhesion kinase. J Cell Biol 1996; 134:793-799 (Pubitemid 26269148)
61. Basson MD, Sanders MA, Gomez R, Hatfield J, Vanderheide R, Thamilselvan V, et al. Focal adhesion kinase protein levels in gut epithelial motility. Am J Physiol Gastrointest Liver Physiol 2006; 291:491-499
62. Maung K, Easty DJ, Hill SP, Bennett DC. Requirement for focal adhesion kinase in tumor cell adhesion. Oncogene 1999; 18:6824-6828